Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - Category: Endocrinology Tags: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Source Type: research
More News: Brain | Cardiology | Cardiovascular | Dapagliflozin | Diabetes | Eating Disorders & Weight Management | Endocrinology | Forxiga | Heart | Metabolic Syndrome | Neurology | Obesity